Murray Stahl’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,247
Closed -$279K 360
2025
Q1
$279K Hold
3,247
﹤0.01% 279
2024
Q4
$254K Hold
3,247
﹤0.01% 290
2024
Q3
$234K Buy
3,247
+150
+5% +$10.6K ﹤0.01% 296
2024
Q2
$213K Hold
3,097
﹤0.01% 280
2024
Q1
$225K Buy
+3,097
New +$207K ﹤0.01% 276

Other funds holding PBH

Murray Stahl's PBH Position: Q2 2025 in Review

Murray Stahl sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 3,247 shares — an estimated $279K sold.

Murray Stahl first reported a position in PBH in Q1 2024 and held it in 5 quarters. The position peaked at $279K in Q1 2025. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • Murray Stahl reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • Murray Stahl sold 3,247 Prestige Consumer Healthcare shares in Q2 2025, an estimated $279K.
  • Murray Stahl first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 5 quarters.
  • Murray Stahl's Prestige Consumer Healthcare position peaked at $279K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.